•
Jun 30, 2013

EyePoint Pharmaceuticals Q4 2013 Earnings Report

Total Revenue
$492K
Previous year: $700K
-29.7%
EPS
-$1.7
Previous year: -$1.1
+54.5%
Gross Profit
-$1.83M
Previous year: -$711K
+157.1%
Cash and Equivalents
$6.9M
Previous year: $4.63M
+49.2%
Free Cash Flow
-$3.4M
Previous year: -$1.84M
+84.3%
Total Assets
$16.2M
Previous year: $20.6M
-21.1%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals